Optiek ter Elzen SRL
Optiek ter Elzen reported total assets of 79,172 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Apr 2026).
The score of Optiek ter Elzen shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +87 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Optiek ter Elzen's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Apr 2026
- Year ended 31 Dec 2024filed on 11 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 20 Jul 2022
Optiek ter Elzen's financial analysis
- Solvency22.1%sector median: 51.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Optiek ter Elzen
Optiek ter Elzen's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0845.305.411
- VAT number
- BE0845305411
- Peppol
- Registered · 0208:0845305411 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 16 Apr 2012
- Registered office
- 2018 Antwerp
- Latest accounts
- 2025 · filed on 14 Apr 2026
- Activity
- Manufacture of medical and dental instruments and supplies (NACE 32500)
Optiek ter Elzen (SRL) has been based in Antwerp since 2012, active in: manufacture of medical and dental instruments and supplies. For 2025, it reports a net loss of 2,917 € and equity of 17,472 €; its revenue is not published. Its solvency stands at 22.1%, below the median of its sector (51.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Optiek ter Elzen
Companies in the same business, of comparable size and area, outside its group.
- Eurodent Manufacture of medical and dental instruments and supplies Ath · balance sheet 87,880 €
- Okula Manufacture of medical and dental instruments and supplies Genk · balance sheet 82,599 €
- D.Optics Manufacture of medical and dental instruments and supplies Vilvoorde · balance sheet 127,682 €
- Mergaerts Optiek Manufacture of medical and dental instruments and supplies Scherpenheuvel-Zichem · balance sheet 105,204 €
- Sarton 1748 Manufacture of watches and clocks Trooz · balance sheet 78,406 €
- Yildiz46 Manufacture of jewellery and related articles Heusden-Zolder · balance sheet 71,050 €
- Astriqs Manufacture of medical and dental instruments and supplies Eeklo · balance sheet 75,211 €
- Nele Blanckaert Manufacture of jewellery and related articles Dilbeek · balance sheet 112,382 €
Frequently asked questions about Optiek ter Elzen
What is the revenue of Optiek ter Elzen?
Optiek ter Elzen files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Optiek ter Elzen?
In Belgium, the VAT number is the company number prefixed with BE: BE0845305411 for Optiek ter Elzen, if the company is VAT-registered. Its company number (CBE) is 0845.305.411.
Where is the registered office of Optiek ter Elzen?
According to the CBE register, the registered office of Optiek ter Elzen is in 2018 Antwerp.
What is the equity of Optiek ter Elzen?
At the close of the 2025 financial year, the equity of Optiek ter Elzen amounts to 17,472 €, a solvency of 22.1% of total assets.
Who manages Optiek ter Elzen?
The register lists 2 active mandates at Optiek ter Elzen. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Optiek ter Elzen
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →